Authenticating Cinnamomum kanehirae! Shui-Tein Chen creates database to identify sources
【新唐人亞太台 2022 年 01 月 11 日訊】Cinnamomum kanehirae that is endemic to Taiwan is a national treasure-level protected plant species. However, there are still unethical businesses illegally harvesting and transporting them so that they can be grown in Mainland China. unethical businesses illegally collecting and transporting them so that they can be grown in Mainland China. Mainland China has even claimed that Antrodia cinnamomea belongs to them. Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure, believes that they are obliged to “authenticate” Cinnamomum kanehirae by using the company’s technology to create an exclusive database for the identification of Cinnamomum kanehirae.
Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure, said that “Antrodia cinnamomea really comes from Taiwan, and the world should know the truth.”
Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure, stated that the Antrodia Cinnamomea is a unique species that is endemic to Taiwan. However, Mainland China claims that the species comes from the Mainland. He provided an example where he was invited to participate in the World Chinese Herbal Medicine Conference organized by the Fujian Antrodia Cinnamomea Research Institute, and the organizer listed Antrodia cinnamomea as Chinese Antrodia cinnamomea. Chairman Chen believed that he is obliged to “authenticate” Cinnamomum kanehirae.
Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure, said that “There should be a way for us to conduct basic identification of the DNA for all of these plants and trees, give them QR codes and that should make it possible to create a database in the future.
Shui-Tein Chen believes that it is necessary to identify the age of thetree through the isotope of Cinnamomum kanehirae, the certification of the origin, and the use of advanced analysis techniques (isozyme analysis and PCR) for the identification of the planting substrate.
Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure said that “When someone transports Antrodia cinnamomea to Beijing or to Sichuan, a lot of Antrodia cinnamomea is already being grown there. I don’t think that Antrodia cinnamomea is an authentic and local medicinal material since it isn’t growing in the appropriate place.”
The output value of Antrodia cinnamomea in Taiwan was as high as NTD$3 billion. However, the incidence of toxic Antrodia cinnamomea in 2013 inflicted heavy damage to the industry even though the relevant units came forward to provide clarification. Shui-Tein Chen said that the Association was established after the incident and seminars were held annually to jointly discuss the development direction of Antrodia cinnamomea in Taiwan.
Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure, said that “If Antrodia cinnamomea is to flourish and used to develop new drugs, there’s a 20-year patent because of the technology used to develop new drugs. Another concept is that since the Cinnamomum kanehirae is a wood that possesses such beautiful colors, perhaps it’s possible to create culture and creative exhibitions around them.”
The first Antrodia cinnamomea art exhibition was held in August 2014 and was a big hit. The art exhibition was expanded into the Antrodia Cinnamomea Cultural Festival in 2019 to exhibit the soft power of Antrodia cinnamomea as the R&D of Taiwanese businesses was in full force. They made a powder extract out of the Antrodia cinnamomea that was used as a compound base, extracted the oil from the Antrodia cinnamomea to develop a variety of products and some businesses even became involved in the research and development of COVID-19 Oral Antiviral drug candidate.
Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure, said that “The medication was being used experimentally against the Delta variant at the P3 Laboratory of the Academia Sinica and the results from the animal trials completed during October seem to be quite promising.”
Shui-Tein Chen also reremember fulfilling corporate social responsibility as he provides aid to patients with rare diseases.
Shui-Tein Chen, chairman of the Antrodia Cinnamomea Association of Taiwan National Treasure, said that “Since Antrodia cinnamomea is endemic to Taiwan, it isn’t something that is accessible onlyby wealthy individuals. Our company hopes that the elderly can use their pensions to gain access to the Antrodia cinnamomea and those who need to consume Antrodia cinnamomea can also gain access to it.”
After years of hard work by the Association, the government, industry, universities and institutes, the Antrodia Cinnamomea industry in Taiwan has shown signs of rejuvenation as the entire industry must collaborate to expand the international market.
Interview and writing by Jin-Jin Li
Photography post production: Hui-mo Chen
相關新聞
-
疫情燒!台3支疫苗進臨床.牛樟芝研究有新進展
2020-09-11 22:58:17全球疫情蔓延,確診人數突破2700萬例。先前,有專家曾表示,秋季疫情會再經歷一波大流行。面對疫情變化,生醫界加緊腳步,找出解方。台灣目前除了在疫苗有新進展,也有研究團隊,針對台灣獨有的牛樟芝進行研究,有新突破。
-
牛樟芝有望抗疫 對抗Delta變種病口服劑通過動物實驗
2021-10-28 21:59:18抗疫口服藥,成為疫苗後下一個焦點。根據生策會統計,全球有700多個COVID-19新藥進入2、3期臨床試驗。其中,1項取得FDA藥證核准、5項為緊急使用授權(EUA),多為臨床上已使用的老藥或研發中的抗病毒藥物,及免疫調節劑與抗體藥物等。
-
牛樟芝國際產業創新研討會 探討永續.展新研發成果
2021-10-29 21:30:50牛樟芝國際產業創新研討會,2天一夜的活動,週四(28日)在南港國家生技研究園區舉行。邀集台灣各界專家學者,共同探討牛樟芝產業未來發展。今年8月,經濟部通過牛樟芝(菇)子實體制定國家標準。對此,業者都樂觀看待。
-
台生技廠發起植樹固碳計畫 4處戒毒村種2千棵牛樟
2022-02-26 21:47:47帶您看到,台灣生技業者攜手民間團體,發起戒毒植樹固碳計畫,25日舉行簽約儀式。由民間團體提供戒毒村土地,生技業者提供台灣原生種牛樟樹苗,預計在全台4個戒毒村,種植約2000棵的牛樟樹。
-
陳水田肩載使命 67歲拿退休金投入新藥開發
2021-03-24 14:32:48台灣生技業研發實力,世界有目共睹,更成立國家生技研究園區,網羅具有研發新藥潛力的公司,72歲的陳水田博士,就是其中一員。5年前陳水田從中研院退休後,把退休金作為創業基金,投入新藥開發,為產業孕育人才。
-
亞洲生技展 550家指標廠參展 聚焦14大應用
2022-07-28 22:15:51亞洲生技大展今天(28日)登場,來自15個國家、550家指標大廠參展。今年以「串接亞洲生技價值鏈」為主題,共規劃14大展區,有哪些新技術應用,帶您了解。
-
民眾保健防疫意識提高 促保健食品市場規模增
2022-06-03 21:35:24民眾保健意識抬頭,加上受疫情影響,更注重自己的健康狀態。除了防疫產品需求,也帶動台灣保健營養食品產值,連續6年正成長。業者也明顯感受,在疫情期間保健食品銷量,至少成長10幾倍。
-
財經趨勢4.0|英特爾籲美不該挺台積 劉德音:不值得回應!
2021-12-04 16:50:41半導體產業是台美合作關鍵項目,不過近期英特爾執行長基辛格,公開喊話美國白宮,認為亞洲公司不應該獲得美國政府補助,還說台灣不是個穩定地方。台積電董事長劉德音,低調表示,「不值得回應,不會中傷同業」;台積電在美國設廠計劃不會受影響。
-
為台灣牛樟芝出處證身!陳水田打造數據庫鑑定來源
2021-12-01 21:19:31台灣原生牛樟木,是國寶級保育樹種。但仍有不肖業者,盜採運送到中國繁殖。中國更宣稱,牛樟芝是屬於中國的。台灣國寶牛樟芝協會理事長陳水田認為,有義務為台灣牛樟木「證身」。藉由公司技術,為牛樟木鑑定,打造專屬的數據庫。
-
肩載使命勤懇務實 陳水田演繹台灣生技好實力
2021-03-27 15:59:54歡迎回來。台灣生技業研發實力,世界有目共睹,更成立國家生技研究園區,網羅具有研發新藥潛力的公司,72歲的陳水田博士,就是其中一員。5年前陳水田從中研院退休後,把退休金作為創業基金,投入新藥開發,為產業孕育人才。
-
打造數據庫鑑定來源 陳水田為台灣牛樟木出處證身!
2022-01-22 15:45:46歡迎回來,台灣原生牛樟木,是國寶級保育樹種,但仍有不肖業者,盜採運送到中國繁殖。中國更宣稱,牛樟芝是屬於中國的。台灣國寶牛樟芝協會理事長陳水田認為,有義務為台灣牛樟木「證身」。藉由公司技術,為牛樟木鑑定,打造專屬的數據庫。
-
打造數據庫鑑定來源 陳水田為台灣牛樟芝出處證身!
2021-12-04 16:23:50歡迎回來,台灣原生牛樟木,是國寶級保育樹種,但仍有不肖業者,盜採運送到中國繁殖。中國更宣稱,牛樟芝是屬於中國的。台灣國寶牛樟芝協會理事長陳水田認為,有義務為台灣牛樟木「證身」。藉由公司技術,為牛樟木鑑定,打造專屬的數據庫。
-
Dr. Chen an entrepreneur with diligence and vision while striving forward in biotech industry
2021-04-27 13:11:28With internationally reputed biotech Research & Development competence, Taiwan established the National Biotechnology Research Park and recruited those with new-drug development capacity and Dr. Shui-Tein Chen is one of them. Retiring from the Academia Si